The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.37BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
154.33x
vs Conglomerates peers
Updated Jul 19, 2026
Revenue (TTM)
630.04MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
1.16%
vs Conglomerates peers
Updated Jul 19, 2026
Beta
1.19x
vs all stocks
Updated Jul 19, 2026
52-Week Change
173.97%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
1.37BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
1.44BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
154.33x
vs Conglomerates peers
Updated Jul 19, 2026
Forward P/E
24.37x
vs Conglomerates peers
Updated Jul 19, 2026
PEG Ratio
1.54x
vs Conglomerates peers
Updated Jul 19, 2026
Price to Sales (TTM)
2.17x
vs Conglomerates peers
Updated Jul 19, 2026
Price to Book (MRQ)
4.37x
vs Conglomerates peers
Updated Jul 19, 2026
Enterprise to Revenue
2.29x
vs Conglomerates peers
Updated Jul 19, 2026
Enterprise to EBITDA
15.97x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.77×.Updated Jul 19, 2026
Gross Margin
24.46%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 30.48%.Updated Jul 19, 2026
Profit Margin
1.16%
vs Conglomerates peers
Updated Jul 19, 2026
Operating Margin
8.20%
vs Conglomerates peers
Updated Jul 19, 2026
Return on Assets (TTM)
5.20%
vs Conglomerates peers
Updated Jul 19, 2026
Return on Equity (TTM)
3.04%
vs Conglomerates peers
Updated Jul 19, 2026
Revenue (TTM)
630.04MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
4.71USDUpdated Jul 19, 2026
Quarterly Revenue Growth
-0.60%
vs Conglomerates peers
Updated Jul 19, 2026
Gross Profit (TTM)
192.04MUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
85.97MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
8.48MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
105.50%
vs Conglomerates peers
Updated Jul 19, 2026
Operating Cash Flow (TTM)
84.57MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
224.50KUSD
vs all stocks (USD)
Updated Jul 19, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Jul 19, 2026
Minority Interest (Equity)
-1.27MUSDFY2025 · Dec 31, 2025
Revenue
630.93MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
474.98MUSDFY2025 · Dec 31, 2025
Gross Profit
155.95MUSDFY2025 · Dec 31, 2025
Operating Income
55.39MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
26.50MUSDFY2025 · Dec 31, 2025
Income Tax Expense
22.30MUSDFY2025 · Dec 31, 2025
Net Income
3.00MUSDFY2025 · Dec 31, 2025
EBIT
43.83MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
80.93MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
100.56MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
17.33MUSDFY2025 · Dec 31, 2025
EPS (Basic)
0.0200USDFY2025 · Dec 31, 2025
EPS (Diluted)
0.0200USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
133.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
133.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
3.00MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
7.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
61.67MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-18.51MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
72.68MUSDFY2025 · Dec 31, 2025
Income Tax Paid
12.54MUSDFY2025 · Dec 31, 2025
Interest Paid
16.82MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
3.00MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
37.10MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
8.43MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
7.09MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
1.08MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
5.79MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-817.00KUSDFY2025 · Dec 31, 2025
Capital Expenditures
-80.18MUSDFY2025 · Dec 31, 2025
Purchase of Investments
0.00USDFY2025 · Dec 31, 2025
Sale of Investments
19.01MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-199.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-61.37MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
390.00KUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.13MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-4.50MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-9.24MUSDFY2025 · Dec 31, 2025
Shares Outstanding
135.30MSharesUpdated Jul 19, 2026
Float Shares
127.64MSharesUpdated Jul 19, 2026
Shares Short
9.20MSharesUpdated Jul 19, 2026
Short Ratio
4.44days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
6.58%
vs all stocks
Updated Jul 19, 2026
% Held by Insiders
5.45%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
81.68%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
35.47MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
0.2620USDUpdated Jul 19, 2026
Total Debt (MRQ)
224.35MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
0.7855x
vs Conglomerates peers
Updated Jul 19, 2026
Current Ratio (MRQ)
2.02x
vs Conglomerates peers
Updated Jul 19, 2026
Book Value per Share (MRQ)
2.12USDUpdated Jul 19, 2026
Total Assets
675.76MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
316.68MUSDFY2025 · Dec 31, 2025
Total Liabilities
393.27MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
359.08MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
236.81MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
156.46MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
72.63MUSDFY2025 · Dec 31, 2025
Accounts Receivable
99.58MUSDFY2025 · Dec 31, 2025
Inventory
115.73MUSDFY2025 · Dec 31, 2025
Accounts Payable
54.52MUSDFY2025 · Dec 31, 2025
Short-term Debt
11.33MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
7.36MUSDFY2025 · Dec 31, 2025
Long-term Debt
214.02MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
4.77MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
1.37MUSDFY2025 · Dec 31, 2025
Retained Earnings
-165.42MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
282.49MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
19.96MUSDFY2025 · Dec 31, 2025
52-Week Low
3.35USDUpdated Jul 19, 2026
52-Week High
12.54USDUpdated Jul 19, 2026
52-Week Change
173.97%
vs all stocks
Updated Jul 19, 2026
Beta
1.19x
vs all stocks
Updated Jul 19, 2026
50-Day MA
10.09USDUpdated Jul 19, 2026
200-Day MA
9.16USDUpdated Jul 19, 2026
Avg 10-Day Volume
1.39MSharesUpdated Jul 19, 2026
Avg 30-Day Volume
1.78MSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
0.0600USDUpdated Jul 19, 2026
Other Income / Expense
-11.56MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.18: safe zoneNotable
Altman Z-Score: 3.18
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $1.37B, above the global median of $1.15BNotable
Market cap (USD): 1,368,835,590Global Median: 1,146,734,693.424
Revenue is $630.04M, above the global median of $520.53MNotable